Navigation Links
Fuse Science Partners With the New England Consulting Group to Advance Technology Licensing Efforts in Pharmaceutical and OTC Categories
Date:8/10/2011

AVENTURA, Fla., Aug. 10, 2011 /PRNewswire/ -- Double Eagle Holdings, Ltd. (OTCQB: DEGH), announced today that it has retained The New England Consulting Group (NECG) in a strategic partnership to advance licensing efforts for the company's proprietary technology throughout the pharmaceutical and over-the-counter (OTC) markets. Double Eagle Holdings is the parent company of Fuse Science, Inc. (www.fusescience.com), the developer of new, proprietary technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.

Fuse Science has successfully developed and maintains the rights to sublingual, buccal, and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly.

"Our proprietary technology effectively penetrates the mucosa and epithelium to achieve complete and enhanced absorption, and it is our firm belief that at this moment we can deliver a wide range of product formulations via these delivery systems," said Rob Davidson, Chief Scientific Officer at Fuse Science.

"We have high confidence that our proprietary technology can effectively produce aspirin, OTC medications, energy and electrolyte products, sleep aids, appetite suppressants, pharmaceutical medications including enhancement products like Viagra and Cialis, along with vitamins and complex nutrition products – it is easy to understand that we must aggressively advance our licensing efforts with the leading companies in these categories," said Brian Tuffin, President and Chief Operating Officer. "Our deliberate strategy is to open licensing discussions with the number 1 and 2 brands in each respective category, and our partnership with The New England Consulting Group is a key enabler to accelerate this effort."

Founded in 1981 and headquartered in Westport, CT, The New England Consulting Group (http://www.necg.net/) is a global leader in marketing and management consulting, providing strategic counsel and business development services to the world's largest and most successful companies.

"After thoroughly reviewing the Fuse Science platform, we believe this proprietary technology will change the face of many major categories of products that we consume each day," said Gaurav Kapoor, Managing Partner and Principal at NECG. "Through our extensive work with the leaders of industry in these categories, we are confident that this partnership has the ability to open new doors of development and consumer satisfaction and we are excited to be working with the Fuse Science team."

About Double Eagle Holdings
Double Eagle Holdings (OTCQB: DEGH.pk) is the holding company of Fuse Science, Inc., an innovative consumer products company based in Aventura, Florida. Fuse Science is the developer of patent-pending conveyance technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals, delivering their benefits faster and more effectively than ever before. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).

Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the company's SEC filings. The company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.


'/>"/>
SOURCE Double Eagle Holdings, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
4. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
5. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
6. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
7. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
8. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
9. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... , June 8, 2017  Less than a ... hit more than 200,000 companies, including hospital networks, in ... heralded as one of the largest online extortion attempts ... the healthcare market, it is imperative that providers understand ... their data from this — and many other very ...
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
Breaking Medicine Technology:
(Date:6/24/2017)... ... June 24, 2017 , ... Genes ... for medications in select Florida and Texas doctors' offices and clinics. This breakthrough ... application of genetic testing recognizes the role genes play in determining an individual's ...
(Date:6/24/2017)... ... June 24, 2017 , ... Dr. Mitchell Mehlman and ... in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable routine and emergency dental ... dentist fit into their patients’ busy lifestyles. Dental365 also gladly work with most ...
(Date:6/24/2017)... ... ... Doorknobs are for convenience, deadbolts are for security. , There are many ways ... alarm system installed. But unless there is a working deadbolt lock that is used ... Locksmith in Killeen, TX says: “In the majority of home burglaries, intruders use force ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... what is needed and will ultimately do significant harm to people with all ... everyone. , "While it leaves in place the Affordable Care Act (ACA) ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... (BCRA), their proposed healthcare bill to repeal and replace the Affordable Care Act ... bill would make significant cuts to Medicaid, a public health insurance program for ...
Breaking Medicine News(10 mins):